Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Podcast By Julio G. Martinez-Clark cover art

Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere
The buy box is not available to display at this moment. We apologize for the inconvenience
To purchase this book, please visit this page again later. For help with any other issue, please call our 24/7 customer service

Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.


What You’ll Learn:

  • Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.
  • Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.
  • Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.


Why Listen?

  • Actionable Playbooks: Reverse-engineer success stories from startups that enrolled cohorts 50% faster and secured Series B funding 12–18 months early.
  • Regulatory Intel: Stay ahead of shifting LATAM, Balkans, and APAC guidelines with on-the-ground experts.
  • Future-Proof Insights: Explore decentralized trials, AI-driven recruitment, and post-trial commercialization in $1B+ markets.

“bioaccess®’s Serbia site activated in 8 weeks-9 months faster than our EU delay.


This podcast is why we partnered with them.”
– Digital Health Startup CEO


New episodes drop weekly. Subscribe to unlock your shortcut to global trial velocity.


Brought to you by bioaccess® – Turning “anywhere” into accelerated FDA/EMA submissions since 2010.

© 2026 Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Economics Hygiene & Healthy Living Leadership Management & Leadership Physical Illness & Disease
Episodes
  • Robert Packard, President at Medical Device Academy, Inc

    Robert Packard, President at Medical Device Academy, Inc
    Mar 27 2026

    In this episode, we are joined by Robert Packard, a seasoned Quality and Regulatory Affairs professional with over 20 years of experience in the medical device industry and a decade in biotech manufacturing validation and scale-up.

    Robert has held leadership roles in multiple startups, co-founded a laparoscopic imaging company, and previously worked as a lead auditor and instructor for a major Notified Body. His expertise spans 510(k) submissions, CE Marking, Canadian Medical Device Licensing, and the development and implementation of ISO 13485-compliant quality systems.

    He is also passionate about education, producing weekly training content focused on current quality and regulatory challenges.
    Show more Show less
    53 mins
  • Kristen Mittal, Co-founder and CEO of Mittal Consulting

    Kristen Mittal, Co-founder and CEO of Mittal Consulting
    Mar 20 2026

    In this episode, we sit down with Kristen Mittal, RAC, PMP, Co-Founder and CEO of Mittal Consulting, a leading regulatory affairs firm supporting medical device innovators.

    With over 10 years of experience across startups and Fortune 500 companies, Kristen brings deep expertise in navigating FDA pathways for Class I, II, and III devices. She shares practical insights on regulatory strategy, accelerating approvals, and building strong post-market frameworks.

    Kristen also highlights her work empowering early-stage ventures and her contributions as an advisory committee member at OHSU, the University of Washington, and UCSF.

    If you're building in MedTech or interested in regulatory strategy, this episode is packed with valuable insights you won’t want to miss.
    Show more Show less
    37 mins
  • Tina Soulis, Founder and Director at Alithia Life Sciences

    Tina Soulis, Founder and Director at Alithia Life Sciences
    Mar 13 2026

    In this episode, we welcome A/Prof Tina Soulis, a life sciences leader with over 30 years of experience in clinical research, biotechnology, and healthcare.

    Founder of Alithia Life Sciences and academic contributor at the University of Melbourne, Tina has held senior roles including CEO of a CRO, Director of an ASX200 company, and VP of Clinical Strategy and Development.

    She is also one of the few Australian clinical development leaders to successfully guide products from lab discovery to regulatory approval.
    Show more Show less
    32 mins
No reviews yet